Patents by Inventor John Pius Dalton

John Pius Dalton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune-modulating agents and uses therefor
    Patent number: 11311610
    Abstract: This invention discloses the use of Heminth Defense Molecules in methods and compositions for modulating immune responses including treating or preventing undesirable or deleterious immune responses.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: April 26, 2022
    Assignee: UNIVERSITY OF TECHNOLOGY SYDNEY
    Inventors: Sheila Donnelly, Mark William Robinson, John Pius Dalton, Joyce To
  • IMMUNE-MODULATING AGENTS AND USES THEREFOR
    Publication number: 20130287806
    Abstract: This invention discloses the use of Heminth Defense Molecules in methods and compositions for modulating immune responses including treating or preventing undesirable or deleterious immune responses.
    Type: Application
    Filed: November 1, 2011
    Publication date: October 31, 2013
    Applicant: UNIVERSITY OF TECHNOLOGY, SYDNEY
    Inventors: Sheila Donnelly, Mark William Robinson, John Pius Dalton, Joyce To
  • Vaccine containing a peroxiredoxin and/or a &bgr;-tubulin
    Patent number: 6676944
    Abstract: Vaccine compositions comprising peroxiredoxin and/or &bgr;-tubulin antigenic material, preferably of Fasciola or Dicrocoelium origin, for use in combating a parasitic infestation of helminths in a mammal, are provided. Also provided are nucleic acid sequences which encode peroxiredoxin and/or &bgr;-tubulin molecules and the amino acid sequences thereof, vectors comprising said nucleic acid sequences and cells transformed with such vectors.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: January 13, 2004
    Inventors: John Pius Dalton, Stuart John Andrews
  • VACCINE CONTAINING A PEROXIREDOXIN AND/OR A BETA-TUBULIN
    Publication number: 20030124137
    Abstract: The present application relates to vaccine compositions comprising peroxiredoxin and/or &bgr;—tubulin antigenic material, preferably of Fasciola or Dicrocoelium origin, for use in combatting a parasitic infestation of helminths in a mammal. It further relates to nucleic acid sequences which encode peroxiredoxin and/or &bgr;—tubulin molecules and the amino-acid sequences thereof, vectors comprising said nucleic acid sequences and cells transformed with such vectors.
    Type: Application
    Filed: February 19, 1999
    Publication date: July 3, 2003
    Inventors: JOHN PIUS DALTON, STUART JOHN ANDREWS